Vaccine Information: ASTRAZENECA COVID-19 VACCINE

ASTRAZENECA COVID-19 VACCINE- azd-1222 injection, suspension
AstraZeneca Pharmaceuticals LP

Package/Label Display Panel – Vial Label

AstraZeneca COVID-19 Vaccine NDC 0310-1222-10

For use under Emergency Use Authorization

Suspension for Intramuscular Injection

After first use, discard after:

6 hours at 20°-25°C (68°-77°F), or

48 hours at 2°-8°C (36°-46°F)

For Exp Date: see

www.azcovid-19.com

Multi-dose vial (10 doses of 0.5 mL)

Package/Label Display Panel – Vial Carton

NDC 0310-1222-15

AstraZeneca COVID-19 Vaccine

For use under Emergency Use Authorization

Suspension for Intramuscular Injection

Store at 2°-8°C (36°-46°F) in original carton to protect from light.

Do not freeze or shake. No preservative.

Discard 6 hours after first use when held at 20°-25°C (68°-77°F).

Discard 48 hours after first use when held at 2°-8°C (36°-46°F).

10 Multi-dose vials

(each vial contains 10 doses of 0.5 mL)

AstraZeneca

ASTRAZENECA COVID-19 VACCINE azd1222 injection, suspension

Product Information Product Type VACCINE Item Code (Source) NDC:0310-1222 Route of Administration INTRAMUSCULAR DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength AZD-1222 (AZD-1222) AZD-1222 50000000000 {VP} in 0.5 mL

Inactive Ingredients Ingredient Name Strength HISTIDINE HISTIDINE MONOHYDROCHLORIDE MAGNESIUM CHLORIDE POLYSORBATE 80 ALCOHOL SUCROSE SODIUM CHLORIDE EDETATE DISODIUM WATER

Packaging # Item Code Package Description Multilevel Packaging 1 NDC:0310-1222-15 10 VIAL, MULTI-DOSE in 1 CARTON contains a VIAL, MULTI-DOSE (0310-1222-10) 1 NDC:0310-1222-10 5 mL in 1 VIAL, MULTI-DOSE This package is contained within the CARTON (0310-1222-15)

Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date Unapproved drug other 12/22/2020

Labeler — AstraZeneca Pharmaceuticals LP (054743190)

Registrant — AstraZeneca PLC (230790719)

Revised: 12/2020 AstraZeneca Pharmaceuticals LP